Drug Profile
ONO 8539
Alternative Names: ONO-8539Latest Information Update: 03 Jul 2017
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Developer Hyogo College of Medicine; Ono Pharmaceutical
- Class
- Mechanism of Action Prostaglandin-E EP1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastro-oesophageal reflux; Overactive bladder
Most Recent Events
- 25 Nov 2014 Phase-I/II clinical trials in Gastro-oesophageal reflux in Japan (PO) (UMIN000015753)
- 31 Mar 2014 Ono Pharmaceutical completes a phase I trial in Healthy volunteers in United Kingdom (NCT01705275)
- 16 Jan 2014 Ono Pharmaceutical completes enrolment in its phase I trial in Healthy volunteers in United Kingdom (NCT01705275)